EventsMOL2NET'18, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 4th ed.
Published
This submission belongs to the session 09. NICEXSM-04: North-Ibero-American Congress on Exp. and Simul. Methods., Valencia, Spain-Talca, Chile-Miami, USA, 2018-2019 of the event MOL2NET'18, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 4th ed.
Published date
17 Dec, 2018
Citation
Maria Francisca Matus, Cristian Vilos, Iván Palomo, COMPUTATIONAL STUDY OF HYBRID PLA-PEG NANOPARTICLES AS ANTIPLATELET DRUG CARRIERS, in Proceedings of MOL2NET'18, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 4th ed., 15 January 2018–20 January 2019, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-04-06008
Share
Email
FaceBook
Twitter
Linkedin

COMPUTATIONAL STUDY OF HYBRID PLA-PEG NANOPARTICLES AS ANTIPLATELET DRUG CARRIERS

1. Thrombosis Research Center, Department of Clinical Biochemistry and Immunohaematology, Faculty of Health Sciences, Universidad de Talca, Talca, Chile.
2. Laboratory of Nanomedicine and Targeted Delivery, Center for Integrative Medicine and Innovative Science, Faculty of Medicine & Center for Bioinformatics and Integrative Biology, Faculty of Biological Sciences, Universidad Andres Bello, Santiago, Chile.
3. Thrombosis Research Center, Department of Clinical Biochemistry and Immunohaematology, Faculty of Health Sciences, Interdisciplinary Excellence Research Program on Healthy Aging (PIEI-ES), Universidad de Talca, Talca, Chile.
4. Laboratory of Nanomedicine and Targeted Delivery, Center for Integrative Medicine and Innovative Science, Faculty of Medicine, Center for Bioinformatics and Integrative Biology, Faculty of Biological Sciences, Universidad Andres Bello, Santiago, Chile
5. Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Universidad de Santiago de Chile. Santiago, Chile
Abstract
Keywords
nanoparticles
platelets
cardiovascular diseases
antiaggregant
Poster
Matus_MFrancisca_Poster.pdf